Catalyst Wire Dossier Catalyst Wire Dossier

131I-labeled MIBG

metaiodobenzylguanidine (MIBG)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 131I-labeled MIBG, covering 2025-07-22 to 2025-07-22. Get the full timeline:

Most recent: Clinical Trial Update: 131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol

See pricing